Recent Advances of Functional Nucleic Acid-based Sensors for Point-of-care Detection of SARS-CoV-2

Overview

Journal Mikrochim Acta

Specialties Biotechnology
Chemistry

Date 2022 Mar 2

PMID 35235065

Authors

Wenxian Zhang

Ying He

Zhe Feng

Jingjing Zhang

Affiliations

Soon will be listed here.

Abstract

This review focuses on critical scientific barriers that the field of point-of-care (POC) testing of SARS-CoV-2 is facing and possible solutions to overcome these barriers using functional nucleic acid (FNA)-based technology. Beyond the summary of recent advances in FNA-based sensors for COVID-19 diagnostics, our goal is to outline how FNA might serve to overcome the scientific barriers that currently available diagnostic approaches are suffering. The first introductory section on the operationalization of the COVID-19 pandemic in historical view and its clinical features contextualizes essential SARS-CoV-2-specific biomarkers. The second part highlights three major scientific barriers for POC COVID-19 diagnosis, that is, the lack of a general method for (1) designing receptors of SARS-CoV-2 variants; (2) improving sensitivity to overcome false negatives; and (3) signal readout in resource-limited settings. The subsequent part provides fundamental insights into FNA and technical tricks to successfully achieve effective COVID-19 diagnosis by using in vitro selection of FNA to overcome receptor design barriers, combining FNA with multiple DNA signal amplification strategies to improve sensitivity, and interfacing FNA with portable analyzers to overcome signal readout barriers. This review concludes with an overview of further opportunities and emerging applications for FNA-based sensors against COVID-19.

Citing Articles

Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials.

Liu Y, Li Y, Hang Y, Wang L, Wang J, Bao N Nano Converg. 2024; 11(1):2.

PMID: 38190075 PMC: 10774473. DOI: 10.1186/s40580-023-00408-z.

Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections.

Akalin P, Yazgan-Karatas A MethodsX. 2023; 11:102372.

PMID: 37744884 PMC: 10511794. DOI: 10.1016/j.mex.2023.102372.

Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care.

Srinivasan Rajsri K, McRae M, Christodoulides N, Dapkins I, Simmons G, Matz H Bioengineering (Basel). 2023; 10(6).

PMID: 37370601 PMC: 10295356. DOI: 10.3390/bioengineering10060670.

Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review.

He Z, Liu C, Li Z, Chu Z, Chen X, Chen X Front Bioeng Biotechnol. 2022; 10:1020444.

PMID: 36312553 PMC: 9606474. DOI: 10.3389/fbioe.2022.1020444.

Comparison of a Blood Self-Collection System with Routine Phlebotomy for SARS-CoV-2 Antibody Testing.

Wixted D, Neighbors C, Pieper C, Wu A, Kingsbury C, Register H Diagnostics (Basel). 2022; 12(8).

PMID: 36010206 PMC: 9406345. DOI: 10.3390/diagnostics12081857.

References

Shi R, Shan C, Duan X, Chen Z, Liu P, Song J . A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020; 584(7819):120-124. DOI: 10.1038/s41586-020-2381-y. View

Ahmad M, Sharma P, Kamai A, Agrawal A, Faruq M, Kulshreshtha A . HRPZyme Assisted Recognition of SARS-CoV-2 infection by Optical Measurement (HARIOM). Biosens Bioelectron. 2021; 187:113280. PMC: 8088041. DOI: 10.1016/j.bios.2021.113280. View

Singh N, Ray P, Carlin A, Magallanes C, Morgan S, Laurent L . Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer. Biosens Bioelectron. 2021; 180:113111. PMC: 7908832. DOI: 10.1016/j.bios.2021.113111. View

de Puig H, Lee R, Najjar D, Tan X, Soeknsen L, Angenent-Mari N . Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Sci Adv. 2021; 7(32). PMC: 8346217. DOI: 10.1126/sciadv.abh2944. View

Lee J, Kim C, Kim S, Min J, Lee M, Lee S . Mix-and-read, one-minute SARS-CoV-2 diagnostic assay: development of PIFE-based aptasensor. Chem Commun (Camb). 2021; 57(79):10222-10225. DOI: 10.1039/d1cc04066a. View

Ray T, Choi J, Bandodkar A, Krishnan S, Gutruf P, Tian L . Bio-Integrated Wearable Systems: A Comprehensive Review. Chem Rev. 2019; 119(8):5461-5533. DOI: 10.1021/acs.chemrev.8b00573. View

Sun M, Liu S, Wei X, Wan S, Huang M, Song T . Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection. Angew Chem Int Ed Engl. 2021; 60(18):10266-10272. PMC: 8014204. DOI: 10.1002/anie.202100225. View

Schmitz A, Weber A, Bayin M, Breuers S, Fieberg V, Famulok M . A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism. Angew Chem Weinheim Bergstr Ger. 2021; 133(18):10367-10373. PMC: 8250900. DOI: 10.1002/ange.202100316. View

Zahradnik J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J . SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021; 6(9):1188-1198. DOI: 10.1038/s41564-021-00954-4. View

10.

Ramanathan S, Gopinath S, Ismail Z, Md Arshad M, Poopalan P . Aptasensing nucleocapsid protein on nanodiamond assembled gold interdigitated electrodes for impedimetric SARS-CoV-2 infectious disease assessment. Biosens Bioelectron. 2021; 197:113735. PMC: 8550887. DOI: 10.1016/j.bios.2021.113735. View

11.

Nguyen H, Bui H, Phan V, Seo T . An internet of things-based point-of-care device for direct reverse-transcription-loop mediated isothermal amplification to identify SARS-CoV-2. Biosens Bioelectron. 2021; 195:113655. PMC: 8458107. DOI: 10.1016/j.bios.2021.113655. View

12.

Peinetti A, Lake R, Cong W, Cooper L, Wu Y, Ma Y . Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors. Sci Adv. 2021; 7(39):eabh2848. PMC: 8457657. DOI: 10.1126/sciadv.abh2848. View

13.

Moitra P, Alafeef M, Dighe K, Frieman M, Pan D . Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles. ACS Nano. 2020; 14(6):7617-7627. DOI: 10.1021/acsnano.0c03822. View

14.

Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M . Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis. 2020; 73(9):e2869-e2874. PMC: 7543315. DOI: 10.1093/cid/ciaa1496. View

15.

Yang K, Chaput J . REVEALR: A Multicomponent XNAzyme-Based Nucleic Acid Detection System for SARS-CoV-2. J Am Chem Soc. 2021; 143(24):8957-8961. DOI: 10.1021/jacs.1c02664. View

16.

Almaghaslah D, Kandasamy G, Almanasef M, Vasudevan R, Chandramohan S . Review on the coronavirus disease (COVID-19) pandemic: Its outbreak and current status. Int J Clin Pract. 2020; 74(11):e13637. PMC: 7435532. DOI: 10.1111/ijcp.13637. View

17.

Samper I, Sanchez-Cano A, Khamcharoen W, Jang I, Siangproh W, Baldrich E . Electrochemical Capillary-Flow Immunoassay for Detecting Anti-SARS-CoV-2 Nucleocapsid Protein Antibodies at the Point of Care. ACS Sens. 2021; 6(11):4067-4075. PMC: 8565458. DOI: 10.1021/acssensors.1c01527. View

18.

Ju Y, Kim J, Park Y, Lee C, Kim K, Hong K . Rapid and accurate clinical testing for COVID-19 by nicking and extension chain reaction system-based amplification (NESBA). Biosens Bioelectron. 2021; 196:113689. PMC: 8526110. DOI: 10.1016/j.bios.2021.113689. View

19.

Zhang R, Wu J, Ao H, Fu J, Qiao B, Wu Q . A Rolling Circle-Amplified G-Quadruplex/Hemin DNAzyme for Chemiluminescence Immunoassay of the SARS-CoV-2 Protein. Anal Chem. 2021; 93(28):9933-9938. DOI: 10.1021/acs.analchem.1c02229. View

20.

Li H, Ren L, Zhang L, Wang Y, Guo L, Wang C . High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients. Emerg Microbes Infect. 2020; 9(1):2707-2714. PMC: 7782020. DOI: 10.1080/22221751.2020.1858700. View